Search research articles
Contact Us
Filters
Showing results (241-250 of 321) with videos related to
Page
of 33
Sort By:
Genome Medicine
|
April 11, 2025
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
L Nicolas Gonzalez Castro, Avishai Gavish, Lillian Bussema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2018
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
Eudocia Q Lee, Dan G Duda, Alona Muzikansky, et al.
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
NPJ Precision Oncology
|
June 7, 2018
Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
Priscilla K Brastianos, Naema Nayyar, Daniel Rosebrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2007
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report
S A Grimm, J S Pulido, K Jahnke, et al.
Plos One
|
August 3, 2017
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
Varun V Prabhu, Amriti R Lulla, Neel S Madhukar, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Neuro-Oncology Advances
|
November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Neuro-Oncology
|
October 6, 2021
Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma
Chong Hyun Suh, Ho Sung Kim, Sung Soo Ahn, et al.
Page
of 33
Search research articles
Search
Showing results (241-250 of 321) with videos related to
Sort By:
Page
of 33
Genome Medicine
|
April 11, 2025
A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
L Nicolas Gonzalez Castro, Avishai Gavish, Lillian Bussema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2018
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
Eudocia Q Lee, Dan G Duda, Alona Muzikansky, et al.
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
NPJ Precision Oncology
|
June 7, 2018
Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
Priscilla K Brastianos, Naema Nayyar, Daniel Rosebrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2007
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report
S A Grimm, J S Pulido, K Jahnke, et al.
Plos One
|
August 3, 2017
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
Varun V Prabhu, Amriti R Lulla, Neel S Madhukar, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Neuro-Oncology Advances
|
November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Neuro-Oncology
|
October 6, 2021
Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma
Chong Hyun Suh, Ho Sung Kim, Sung Soo Ahn, et al.
Page
of 33